RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Deepull

Deepull

Direct-from-blood multiplex PCR targeting 95% of sepsis-causing pathogens

Latest funding

$57M Series B+ ·

Led by Columbus Venture Partners · Source: startupintros.com

Total raised: $73.75M across 3 sourced rounds

All 3 rounds ↓
Website: deepull.com.
LinkedIn: deepull.
Category: Health and bio.
Sectors: Biotechnology, Life Science.
Stage: Series B+.
Based in: Barcelona, Spain.
Founded: 2019.
Total raised: $73.75M in 3 sourced rounds.
Last round: Apr 30, 2025 · 565 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredSep 6, 2019 (7 years old)
TIMELINE · MONEY RAISED

Deepull | 299 days from website to first raise on record

Raised $74M in 3 sourced rounds·1 signal before the first raise
$18M$37M$55M$74MOCTOCTOCTOCTOCTOCTOCTOCT$74M||WEBSITE CREATED · SEP 6, 2019$4M Series A · Jul 1, 2020$4M A · JUL '20$12.75M Series B+ · Oct 20, 2022$12.75M B+ · OCT '22$57M Series B+ · Apr 30, 2025$57M B+ · APR '25

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Timeline

  1. Website created

Founders and team

Investors

Similar Health and bio companies

Other companies backed by Columbus Venture Partners

Columbus Venture Partners portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/deepull (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy